Table 2. The pathogen eradication data on the basis of the time lag between the end of therapy and the end of the follow-up period.
| Time | End of treatment | 3–5 months | 6–8 months | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Group 1 | Group 2 | Group 1 | Group 2 | Group 1 | Group 2 | |||||||
| n | % | n | % | n | % | n | % | n | % | n | % | |
| No. of evaluated patients | 39 | 100 | 62 | 100 | 38 | 97.4 | 57 | 91.9 | 35 | 89.7 | 53 | 85.5 |
| Eradication | 32 | 82.0 | 54 | 87.1 | 20 | 51.3* | 46 | 74.2 | 17 | 43.6* | 45 | 72.6 |
| Relapse | — | — | 9 | 5 | 3 | — | ||||||
| Superinfection | — | — | 3 | 3 | 0 | 1 | ||||||
| Lost to follow-up | — | — | 1 | 5 | 4 | 9 | ||||||
Group 1: chronic bacterial prostatitis with prostatic calculi; Group 2: chronic bacterial prostatitis without prostatic calculi; —:no corresponding item.
*P<0.01, vs. Group 2.